Related Experiment Video
Updated: Jun 10, 2026
08:10
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Osteopontin in Atrial Fibrillation and Atrial Remodeling
Argen Mamazhakypov1, Balram Neupane2, Akpay Sarybaev3
1Department of Internal Medicine, Institute for Lung Health, Cardio-Pulmonary Institute, Member of the German Center for Lung Research Justus Liebig University of Giessen Giessen Germany.
Journal of the American Heart Association
|June 9, 2026
Summary
Osteopontin plays a key role in atrial remodeling and the development of atrial fibrillation (AF). Elevated osteopontin levels may serve as a biomarker for this common heart arrhythmia.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Atrial fibrillation (AF) is a prevalent cardiac arrhythmia with poorly understood mechanisms, often involving atrial inflammation and fibrosis.
- Osteopontin, an extracellular matrix protein, is increasingly recognized for its involvement in cardiovascular diseases.
Purpose of the Study:
- To review the role of osteopontin in atrial remodeling and arrhythmogenesis.
- To examine osteopontin's molecular mechanisms in structural and electrical atrial remodeling.
- To assess osteopontin's potential as a biomarker for atrial fibrillation.
Main Methods:
- Review of recent human and in vitro studies on osteopontin's function in cardiovascular disease.
- Analysis of osteopontin's modulation of cellular processes like fibroblast activation and cytokine production.
- Examination of osteopontin's association with atrial fibrillation prevalence and progression.
Main Results:
- Osteopontin is implicated in atrial myocardial inflammation and fibrosis, key to AF pathogenesis.
- Circulating osteopontin levels correlate with atrial fibrillation presence and progression in human studies.
- In vitro data show osteopontin influences fibroblast activation, extracellular matrix remodeling, and inflammation.
Conclusions:
- Osteopontin is a significant mediator of atrial remodeling and arrhythmogenesis.
- Osteopontin holds potential as a valuable biomarker for atrial fibrillation.
- Understanding osteopontin's molecular role may lead to novel therapeutic strategies for AF.
